Charles Schwab’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.2M Sell
1,399,125
-34,980
-2% -$1.63M 0.01% 889
2026
Q1
$51.8M Buy
1,434,105
+84,472
+6% +$3.53M 0.01% 1127
2025
Q4
$63.6M Buy
1,349,633
+24,820
+2% +$1.05M 0.01% 994
2025
Q3
$43M Buy
1,324,813
+359,640
+37% +$12.8M 0.01% 1255
2025
Q2
$39.8M Buy
965,173
+38,383
+4% +$1.48M 0.01% 1247
2025
Q1
$38.7M Buy
926,790
+50,537
+6% +$2.63M 0.01% 1241
2024
Q4
$51.4M Sell
876,253
-23,385
-3% -$1.38M 0.01% 1113
2024
Q3
$62.1M Buy
899,638
+94,612
+12% +$6.11M 0.01% 951
2024
Q2
$51.4M Buy
805,026
+55,284
+7% +$4.16M 0.01% 1059
2024
Q1
$70.4M Buy
749,742
+1,940
+0.3% +$156K 0.02% 796
2023
Q4
$54.9M Buy
747,802
+34,355
+5% +$2.2M 0.01% 903
2023
Q3
$44.4M Buy
713,447
+790
+0.1% +$53.1K 0.01% 959
2023
Q2
$52.7M Sell
712,657
-8,676
-1% -$661K 0.02% 831
2023
Q1
$56.9M Buy
721,333
+8,393
+1% +$606K 0.02% 751
2022
Q4
$48.7M Buy
712,940
+23,185
+3% +$1.47M 0.02% 830
2022
Q3
$36.6M Buy
689,755
+38,844
+6% +$2.32M 0.01% 961
2022
Q2
$40.9M Buy
650,911
+19,802
+3% +$1.21M 0.01% 889
2022
Q1
$40.6M Buy
631,109
+19,265
+3% +$1.32M 0.01% 1020
2021
Q4
$51.3M Buy
611,844
+14,664
+2% +$1.18M 0.02% 873
2021
Q3
$46.6M Sell
597,180
-262,219
-31% -$21.8M 0.02% 926
2021
Q2
$65.3M Buy
859,399
+23,895
+3% +$1.67M 0.02% 691
2021
Q1
$53.7M Sell
835,504
-14,321
-2% -$860K 0.02% 777
2020
Q4
$46M Buy
849,825
+8,022
+1% +$385K 0.02% 814
2020
Q3
$33.5M Sell
841,803
-811
-0.1% -$33.8K 0.02% 889
2020
Q2
$34.3M Buy
842,614
+29,408
+4% +$1.16M 0.02% 811
2020
Q1
$29.2M Buy
813,206
+25,366
+3% +$1.18M 0.02% 759
2019
Q4
$40.2M Buy
787,840
+3,317
+0.4% +$158K 0.02% 756
2019
Q3
$34.5M Buy
784,523
+36,529
+5% +$1.64M 0.02% 800
2019
Q2
$37.4M Sell
747,994
-3,564
-0.5% -$150K 0.02% 731
2019
Q1
$28.9M Sell
751,558
-66,720
-8% -$2.41M 0.02% 882
2018
Q4
$24.4M Buy
818,278
+47,365
+6% +$1.49M 0.02% 862
2018
Q3
$25.8M Buy
770,913
+103,791
+16% +$3.42M 0.02% 980
2018
Q2
$19.4M Buy
667,122
+47,728
+8% +$1.45M 0.01% 1107
2018
Q1
$18.5M Buy
619,394
+21,779
+4% +$707K 0.01% 1057
2017
Q4
$20.5M Buy
597,615
+18,066
+3% +$592K 0.02% 958
2017
Q3
$17.2M Buy
579,549
+24,524
+4% +$706K 0.02% 1041
2017
Q2
$16M Buy
555,025
+30,500
+6% +$785K 0.02% 1026
2017
Q1
$12.2M Buy
524,525
+24,115
+5% +$566K 0.01% 1172
2016
Q4
$10.6M Buy
500,410
+19,975
+4% +$437K 0.01% 1210
2016
Q3
$10.9M Buy
480,435
+25,715
+6% +$589K 0.01% 1106
2016
Q2
$10.3M Buy
454,720
+58,920
+15% +$1.57M 0.01% 1043
2016
Q1
$11.1M Buy
395,800
+43,863
+12% +$1.09M 0.01% 977
2015
Q4
$8.54M Buy
351,937
+20,032
+6% +$416K 0.01% 1127
2015
Q3
$5.45M Buy
331,905
+22,784
+7% +$443K 0.01% 1408
2015
Q2
$6.31M Buy
309,121
+28,815
+10% +$582K 0.01% 1393
2015
Q1
$5.18M Buy
280,306
+8,857
+3% +$168K 0.01% 1492
2014
Q4
$5.33M Buy
271,449
+16,400
+6% +$316K 0.01% 1399
2014
Q3
$4.72M Buy
255,049
+14,882
+6% +$318K 0.01% 1405
2014
Q2
$5.83M Buy
240,167
+1,587
+0.7% +$34.4K 0.01% 1272
2014
Q1
$5.44M Buy
238,580
+30,147
+14% +$658K 0.01% 1268
2013
Q4
$4.12M Buy
208,433
+16,039
+8% +$315K 0.01% 1418
2013
Q3
$3.99M Sell
192,394
-35,461
-16% -$678K 0.01% 1348
2013
Q2
$3.73M Buy
+227,855
New +$3.94M 0.01% 1301

Other funds holding BRKR

Charles Schwab's BRKR Position: Q2 2026 in Review

Charles Schwab reduced its Bruker (BRKR) stake by 2.4% in Q2 2026, selling an estimated $1.63M and leaving 1,399,125 shares worth $84.2M. The position accounts for 0.01% of the portfolio, ranked #889.

Charles Schwab first reported a position in BRKR in Q2 2013 and has held it in 53 quarters since. 414 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Charles Schwab held 1,399,125 shares of Bruker worth $84.2M as of Q2 2026.
  • Charles Schwab sold 34,980 Bruker shares in Q2 2026, an estimated $1.63M.
  • Bruker made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #889 holding.
  • Charles Schwab first reported a position in Bruker in Q2 2013 and has held it in 53 quarters since.
  • 414 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.